Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high risk acute myeloid leukemia or myelodysplastic syndrome.
暂无分享,去创建一个
P. Chevallier | S. Thépot | L. Planche | T. Guillaume | C. Orvain | P. Peterlin | S. François | C. Fronteau | P. Céballos | A. Garnier | A. Bourgeois | A. Giltat | Y. Bris